A common flavonol found in many fruits, vegetables and grains has been linked to tumor reduction and as a tool in battling leukemia.
According to a study published in the October 2014 online edition of the American Association for Cancer Research, the compound is a candidate in the treatment of blood malignancies.
Quercetin was studied in vitro and in vivo using human leukemia cells that were exposed to quercetin. Their reaction was then evaluated.
Results demonstrated an antioxidant activity and resulted in an increased cancer/leukemia cell-arrest.
In vivo use of quercetin reduced tumor volume and confirmed in vitro results regarding cancer cell death. Researchers conclude that quercetin should be developed as an antitumor agent for blood malignancies.
